PRKAA1 and neurodegenerative disease: It is therefore vital to further evaluate the sensitivity of different AMPK subtypes to various AMPK activators and the exact roles of AMPK holoenzymes composed of different subunits in neurons and glia during the progression of neurodegenerative diseases.